peter md tirzepatide & Semaglutide Weight Loss but the FDA has not evaluated the medications for safety Could GLP-1s impact aging and

We take every report seriously Every scam activity reported to us is treated seriously and we conduct thorough investigations to ensure prompt and appropriate action is taken

They are not as accurate as DEXA for a single measurement, but tracking trends over time still provides useful directional information

Patients should be reassured that regulatory authorities continue to prioritise medication safety whilst recognising the substantial benefits these medicines offer for metabolic health

Barriers include limited provider availability, long wait times for specialists, insurance prior authorization requirements that take weeks with no guarantee of approval, and many plans not covering weight loss medications at all